297 related articles for article (PubMed ID: 30590315)
1. Are the Statins promising antifungal agents against invasive candidiasis?
Lima WG; Alves-Nascimento LA; Andrade JT; Vieira L; de Azambuja Ribeiro RIM; Thomé RG; Dos Santos HB; Ferreira JMS; Soares AC
Biomed Pharmacother; 2019 Mar; 111():270-281. PubMed ID: 30590315
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: Potent in vitro and in vivo fungicidal agents against Candida spp.
Andrade JT; Lima WG; Sousa JF; Saldanha AA; Nívea Pereira De Sá ; Morais FB; Prates Silva MK; Ribeiro Viana GH; Johann S; Soares AC; Araújo LA; Antunes Fernandes SO; Cardoso VN; Siqueira Ferreira JM
Eur J Med Chem; 2021 Jan; 210():113048. PubMed ID: 33316690
[TBL] [Abstract][Full Text] [Related]
3. Novel Preclinical Study of Galloylquinic Acid Compounds from
Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
[TBL] [Abstract][Full Text] [Related]
4. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
5. Antifungal effects of statins.
Tavakkoli A; Johnston TP; Sahebkar A
Pharmacol Ther; 2020 Apr; 208():107483. PubMed ID: 31953128
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.
Nash JD; Burgess DS; Talbert RL
J Med Microbiol; 2002 Feb; 51(2):105-109. PubMed ID: 11863260
[TBL] [Abstract][Full Text] [Related]
7. Insights on the anticandidal activity of non-antifungal drugs.
Moraes DC; Ferreira-Pereira A
J Mycol Med; 2019 Sep; 29(3):253-259. PubMed ID: 31399349
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.
Wong SS; Kao RY; Yuen KY; Wang Y; Yang D; Samaranayake LP; Seneviratne CJ
PLoS One; 2014; 9(1):e85836. PubMed ID: 24465737
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study.
Rana R; Sharma R; Kumar A
Curr Mol Med; 2019; 19(7):506-524. PubMed ID: 31109273
[TBL] [Abstract][Full Text] [Related]
11. Exploring synergy between azole antifungal drugs and statins for Candida auris.
Halliday C; Kim HY; Tay E; Chen SCA; Alffenaar JW
J Antimicrob Chemother; 2023 Dec; 78(12):2824-2829. PubMed ID: 37823357
[TBL] [Abstract][Full Text] [Related]
12. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
13. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
[TBL] [Abstract][Full Text] [Related]
14. Anti-Candida albicans natural products, sources of new antifungal drugs: A review.
Zida A; Bamba S; Yacouba A; Ouedraogo-Traore R; Guiguemdé RT
J Mycol Med; 2017 Mar; 27(1):1-19. PubMed ID: 27842800
[TBL] [Abstract][Full Text] [Related]
15. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
16. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
Cabral ME; Figueroa LI; Fariña JI
Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Pesti M; Papp T; Vágvölgyi C
FEMS Microbiol Lett; 2010 Jun; 307(2):175-84. PubMed ID: 20636975
[TBL] [Abstract][Full Text] [Related]
20. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]